FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376869049> ?p ?o ?g. }

• W4376869049 endingPage "105636" @default.
• W4376869049 startingPage "105636" @default.
• W4376869049 abstract "Although the clinical manifestation of COVID-19 is mainly respiratory symptoms, approximately 20% of patients suffer from cardiac complications. COVID-19 patients with cardiovascular disease have higher severity of myocardial injury and poor outcomes. The underlying mechanism of myocardial injury caused by SARS-CoV-2 infection remains unclear. Using a non-transgenic mouse model infected with Beta variant (B.1.351), we found that the viral RNA could be detected in lungs and hearts of infected mice. Pathological analysis showed thinner ventricular wall, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in hearts of infected mice. We also found that SARS-CoV-2 could infect cardiomyocytes and produce infectious progeny viruses in human pluripotent stem cell-derived cardiomyocyte-like cells (hPSC-CMs). SARS-CoV-2 infection caused apoptosis, reduction of mitochondrial integrity and quantity, and cessation of beating in hPSC-CMs. In order to dissect the mechanism of myocardial injury caused by SARS-CoV-2 infection, we employed transcriptome sequencing of hPSC-CMs at different time points after viral infection. Transcriptome analysis showed robust induction of inflammatory cytokines and chemokines, up-regulation of MHC class I molecules, activation of apoptosis signaling and cell cycle arresting. These may cause aggravate inflammation, immune cell infiltration, and cell death. Furthermore, we found that Captopril (hypotensive drugs targeting ACE) treatment could alleviate SARS-CoV-2 induced inflammatory response and apoptosis in cardiomyocytes via inactivating TNF signaling pathways, suggesting Captopril may be beneficial for reducing COVID-19 associated cardiomyopathy. These findings preliminarily explain the molecular mechanism of pathological cardiac injury caused by SARS-CoV-2 infection, providing new perspectives for the discovery of antiviral therapeutics." @default.
• W4376869049 created "2023-05-18" @default.
• W4376869049 creator A5021353576 @default.
• W4376869049 creator A5023693252 @default.
• W4376869049 creator A5029113438 @default.
• W4376869049 creator A5029548962 @default.
• W4376869049 creator A5045881250 @default.
• W4376869049 creator A5058673686 @default.
• W4376869049 creator A5061780047 @default.
• W4376869049 creator A5064182719 @default.
• W4376869049 creator A5064317688 @default.
• W4376869049 creator A5074140465 @default.
• W4376869049 creator A5079563757 @default.
• W4376869049 creator A5082365446 @default.
• W4376869049 creator A5089354127 @default.
• W4376869049 creator A5091964022 @default.
• W4376869049 creator A5091964023 @default.
• W4376869049 date "2023-07-01" @default.
• W4376869049 modified "2023-10-14" @default.
• W4376869049 title "SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril" @default.
• W4376869049 cites W1964982019 @default.
• W4376869049 cites W1975183982 @default.
• W4376869049 cites W2011903225 @default.
• W4376869049 cites W2023670145 @default.
• W4376869049 cites W2029971767 @default.
• W4376869049 cites W2035618305 @default.
• W4376869049 cites W2085099489 @default.
• W4376869049 cites W2098492050 @default.
• W4376869049 cites W2102278945 @default.
• W4376869049 cites W2104620139 @default.
• W4376869049 cites W2117407305 @default.
• W4376869049 cites W2131271579 @default.
• W4376869049 cites W2138207763 @default.
• W4376869049 cites W2153834107 @default.
• W4376869049 cites W2155045770 @default.
• W4376869049 cites W2163809288 @default.
• W4376869049 cites W2165798592 @default.
• W4376869049 cites W2179438025 @default.
• W4376869049 cites W2353041718 @default.
• W4376869049 cites W2405505865 @default.
• W4376869049 cites W2756541052 @default.
• W4376869049 cites W2898533761 @default.
• W4376869049 cites W3003217347 @default.
• W4376869049 cites W3012747666 @default.
• W4376869049 cites W3013231340 @default.
• W4376869049 cites W3015726950 @default.
• W4376869049 cites W3021880084 @default.
• W4376869049 cites W3022580747 @default.
• W4376869049 cites W3035819488 @default.
• W4376869049 cites W3036500399 @default.
• W4376869049 cites W3036887118 @default.
• W4376869049 cites W3037490279 @default.
• W4376869049 cites W3037945517 @default.
• W4376869049 cites W3041348343 @default.
• W4376869049 cites W3045195423 @default.
• W4376869049 cites W3045497278 @default.
• W4376869049 cites W3057443923 @default.
• W4376869049 cites W3081932525 @default.
• W4376869049 cites W3087106210 @default.
• W4376869049 cites W3089031101 @default.
• W4376869049 cites W3091944910 @default.
• W4376869049 cites W3116055094 @default.
• W4376869049 cites W3122343326 @default.
• W4376869049 cites W3131708313 @default.
• W4376869049 cites W3139224802 @default.
• W4376869049 cites W3155641120 @default.
• W4376869049 cites W3165656738 @default.
• W4376869049 cites W3194625583 @default.
• W4376869049 cites W4200112848 @default.
• W4376869049 cites W4232403455 @default.
• W4376869049 cites W4239797347 @default.
• W4376869049 cites W4281569137 @default.
• W4376869049 cites W4362048428 @default.
• W4376869049 doi "https://doi.org/10.1016/j.antiviral.2023.105636" @default.
• W4376869049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37207821" @default.
• W4376869049 hasPublicationYear "2023" @default.
• W4376869049 type Work @default.
• W4376869049 citedByCount "0" @default.
• W4376869049 crossrefType "journal-article" @default.
• W4376869049 hasAuthorship W4376869049A5021353576 @default.
• W4376869049 hasAuthorship W4376869049A5023693252 @default.
• W4376869049 hasAuthorship W4376869049A5029113438 @default.
• W4376869049 hasAuthorship W4376869049A5029548962 @default.
• W4376869049 hasAuthorship W4376869049A5045881250 @default.
• W4376869049 hasAuthorship W4376869049A5058673686 @default.
• W4376869049 hasAuthorship W4376869049A5061780047 @default.
• W4376869049 hasAuthorship W4376869049A5064182719 @default.
• W4376869049 hasAuthorship W4376869049A5064317688 @default.
• W4376869049 hasAuthorship W4376869049A5074140465 @default.
• W4376869049 hasAuthorship W4376869049A5079563757 @default.
• W4376869049 hasAuthorship W4376869049A5082365446 @default.
• W4376869049 hasAuthorship W4376869049A5089354127 @default.
• W4376869049 hasAuthorship W4376869049A5091964022 @default.
• W4376869049 hasAuthorship W4376869049A5091964023 @default.
• W4376869049 hasBestOaLocation W43768690491 @default.
• W4376869049 hasConcept C104317684 @default.
• W4376869049 hasConcept C126322002 @default.
• W4376869049 hasConcept C13373296 @default.

• next